Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewCell biologyEndocrinology Open Access | 10.1172/JCI187341

Limiting ER-associated degradation capacity triggers acute and chronic effects on insulin biosynthesis

Anoop Arunagiri,1 Leena Haataja,1 Maroof Alam,1 Noah F. Gleason,1 Emma Mastroianni,1 Chao-Yin Cheng,2 Sami Bazzi Onton,1 Jeffrey Knupp,2 Ibrahim Metawea,1 Anis Hassan,1 Dennis Larkin,1 Deyu Fang,3 Billy Tsai,2 Ling Qi,4 and Peter Arvan1

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Arunagiri, A. in: PubMed | Google Scholar |

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Haataja, L. in: PubMed | Google Scholar |

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Alam, M. in: PubMed | Google Scholar |

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Gleason, N. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Mastroianni, E. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Cheng, C. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Bazzi Onton, S. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Knupp, J. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Metawea, I. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Hassan, A. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Larkin, D. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Fang, D. in: PubMed | Google Scholar |

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Tsai, B. in: PubMed | Google Scholar

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Qi, L. in: PubMed | Google Scholar |

1Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, United States of America

2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America

3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, United States of America

4Department of Molecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, United States of America

Find articles by Arvan, P. in: PubMed | Google Scholar |

Published November 18, 2025 - More info

J Clin Invest. https://doi.org/10.1172/JCI187341.
Copyright © 2025, Arunagiri et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published November 18, 2025 - Version history
View PDF
Abstract

In pancreatic β-cells, misfolded proinsulin is a substrate for Endoplasmic Reticulum-Associated protein Degradation (ERAD) via HRD1/SEL1L. β-cell HRD1 activity is alternately reported to improve, or impair, insulin biogenesis. Further, while β-cell SEL1L deficiency causes HRD1 hypofunction and diminishes islet insulin content; reports conflict as to whether β-cell ERAD deficiency increases or decreases proinsulin levels. Here we’ve examined β-cell-specific Hrd1-KO mice (chronic deficiency), plus rodent (and human islet) β-cells treated acutely with HRD1 inhibitor. β-Hrd1-KO mice developed diabetes with decreased islet proinsulin yet a relative increase of misfolded proinsulin re-distributed to the ER; upregulated biochemical markers of β-cell ER stress and autophagy; electron microscopic evidence of ER enlargement and decreased insulin granule content; and increased glucagon-positive islet cells. Misfolded proinsulin was also increased in islets treated with inhibitors of lysosomal degradation. Preceding any loss of total proinsulin, acute HRD1 inhibition triggered increased nonnative proinsulin, increased phospho-eIF2ɑ with inhibited proinsulin synthesis, and increased LC3b-II (the abundance of which requires expression of SigmaR1). We posit a subset of proinsulin molecules undergoes HRD1-mediated disposal. When HRD1 is unavailable, misfolded proinsulin accumulates, accompanied by increased phospho-eIF2ɑ that limits further proinsulin synthesis, plus SigmaR1-dependent autophagy activation, ultimately lowering steady-state β-cell proinsulin (and insulin) levels — triggering diabetes.

Graphical Abstract
graphical abstract
Supplemental material

View

View Unedited blot and gel images

Version history
  • Version 1 (November 18, 2025): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts